Overall, this data proposes lnc191 as a key driver during the development of ESCC and reveals the participation of the activated GRP78/ERK/MAPK axis in the ESCC progression mediated by lnc191. The gene discussed is MAPK1; the disease is esophageal squamous cell carcinoma.